Assignee
EVOLVE BIOSYSTEMS INC
US·2 granted patents·19 pending applications·2 citations·filing 2015–2022
Top patents by PatentIndex Score
21 records- 0180US11318175B2Method for facilitating maturation of the mammalian immune systemEVOLVE BIOSYSTEMS INC·Filed 2017·Granted May 3, 2022·1 cites·23 claims
- 0278US10716816B2Activated bifidobacteria and methods of use thereofEVOLVE BIOSYSTEMS INC·Filed 2015·Granted Jul 21, 2020·1 cites·22 claims
- 0369US2020237836A1Compositions that metabolize or sequester free sugar monomers and uses thereofEVOLVE BIOSYSTEMS INC·Filed 2019·Application pending·0 cites
- 0457US2020397837A1Activated bifidobacteria and methods of use thereofEVOLVE BIOSYSTEMS INC·Filed 2020·Application pending·0 cites
- 0555US2020245667A1Oligosaccharide compositions and their use during transitional phases of the mammalian gut microbiomeEVOLVE BIOSYSTEMS INC·Filed 2018·Application pending·0 cites
- 0653US2021161924A1Novel oligosaccharides for use in prebiotic applicationsEVOLVE BIOSYSTEMS INC·Filed 2019·Application pending·0 cites
- 0752US2020345055A1Activation of conditionally-expressed oligosaccharide pathways during fermentation of probiotic strainsEVOLVE BIOSYSTEMS INC·Filed 2019·Application pending·0 cites
- 0851US2022248738A1NUTRITIVE COMPOSITIONS WITH SECRETED IgA, MILK FAT GLOBULE MEMBRANE COMPONENTS AND/OR BIFIDOBACTERIUMEVOLVE BIOSYSTEMS INC·Filed 2020·Application pending·0 cites
- 0949US2022010267A1Compostions and method of use for h5 competent bifidobacterium longum subsp. infantisEVOLVE BIOSYSTEMS INC·Filed 2019·Application pending·0 cites
- 1047US2019069586A1Food Compositions for WeaningEVOLVE BIOSYSTEMS INC·Filed 2017·Application pending·0 cites
- 1147US2020046782A1Transient Commensal Microorganism for Improving Gut HealthEVOLVE BIOSYSTEMS INC·Filed 2017·Application pending·0 cites
- 1246US2018104157A1Delivering non-pathogenic, intestinally beneficial bacteria to a patient having a feeding tubeEVOLVE BIOSYSTEMS INC·Filed 2016·Application pending·0 cites
- 1345US2024207403A1Personalized immunotherapy using intestinal metabolitesEVOLVE BIOSYSTEMS INC·Filed 2022·Application pending·0 cites
- 1444US2022273733A1Nutritive compositions with bioactive proteinsEVOLVE BIOSYSTEMS INC·Filed 2020·Application pending·0 cites
- 1540US2021308196A1Compositions and methods to promote host defense and stimulate, expand, and/or reset t cell repertoiresEVOLVE BIOSYSTEMS INC·Filed 2019·Application pending·0 cites
- 1640US2021069268A1Metabolomic revision of mammalian infantsEVOLVE BIOSYSTEMS INC·Filed 2018·Application pending·0 cites
- 1739US2022081708A1Diagnosis and treatment of dysbiosis-associated with necEVOLVE BIOSYSTEMS INC·Filed 2020·Application pending·0 cites
- 1838US2018078589A1Compositions that Metabolize or Sequester Free Sugar Monomers and Uses ThereofEVOLVE BIOSYSTEMS INC·Filed 2016·Application pending·0 cites
- 1938US2020385777A1Method for determining dysbiosis in the intestinal microbiomeEVOLVE BIOSYSTEMS INC·Filed 2019·Application pending·0 cites
- 2036US2018267037A1Method for the noninvasive detection of activated bifidobacteriaEVOLVE BIOSYSTEMS INC·Filed 2015·Application pending·0 cites
- 2133US2020206732A1Methods and apparatus for collecting and testing solid or semi-solid materialsEVOLVE BIOSYSTEMS INC·Filed 2018·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →